Health economic evaluation of disease management programs Wolfgang Greiner Editorial Pages: 191 - 196
The economic and quality of life impact of hypoglycemia Jonas LundkvistChristian BerneLinus Jönsson ❚ Pages: 197 - 202
Use of a decision analysis model to assess the medicoeconomic implications of FDG PET imaging in diagnosing a solitary pulmonary nodule Catherine LejeuneKazem Al ZahouriFrancis Guillemin Original Papers Pages: 203 - 214
Institutional arrangements and efficiency of health care delivery systems Vasanthakumar N. Bhat Original Papers Pages: 215 - 222
A cross-national perspective on cost of illness Johan J. PolderWillem Jan MeerdingPaul J. van der Maas Original Papers Pages: 223 - 232
Influenza treatment with neuraminidase inhibitors Beate SanderMarlene GyldmarkRito Bergemann Original Papers Pages: 244 - 252
Comparison of general practitioner records and patient self-report questionnaires for estimation of costs Hema MistryMartin Buxtonon behalf of the Assessing Health Economics of Antidepressants (AHEAD) Team Original Papers Pages: 261 - 266
The potential impact of implementing a system of generic substitution on the community drug schemes in Ireland Lesley TilsonKathleen BennettMichael Barry Original Papers Pages: 267 - 273
Reimbursement and clinical guidance for pharmaceuticals in Sweden Anders AnellUlf Persson Pricing and Reimbursement Systems in Europe Pages: 274 - 279